Skip to main content

Living with Epidermolysis Bullosa: Reviewing the Impact on Individuals’ Quality of Life

  • Chapter
  • First Online:
Blistering Diseases

Abstract

Quality of life is an abstract, multidimensional construct assessing the physical, psychological and social aspects of an individual’s condition. Quality of life measurements are especially pertinent in dermatological conditions due to the high level of psychosocial impact they have on the individual. In epidermolysis bullosa (EB), generic quality of life assessments have been used to compare the burden of EB with other dermatological conditions as well as assess the social, emotional and psychological burden of living with EB. Other more recent studies have developed EB-specific quality of life measurement tools, and qualitative studies have descriptively examined the experience of living with EB. Future uses of quality of life measurements in EB may include assessment of new therapeutic interventions as well as longitudinal quality of life studies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Horn HM, Tidman MJ. Quality of life in epidermolysis bullosa. Clin Exp Dermatol. 2002;27:707–10.

    Article  CAS  PubMed  Google Scholar 

  2. Frew JW, Martin LK, Nijsten. Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: an EB-specific quality of life instrument. Br J Dermatol. 2009;161:1323–30.

    Article  CAS  PubMed  Google Scholar 

  3. WHOQOL Group. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 1995;41:1403–9.

    Article  Google Scholar 

  4. World Health Organization. Constitution of the World Health Organization. In: Basic documents. 45th ed. Supplement, October 2006 from the fifty-first world health assembly. Geneva: WHO; 2006; p. 1.

    Google Scholar 

  5. Both H, Essink-Bot M, Bussschbach J, et al. Critical review of generic and dermatology-specific health-related quality of life instruments. J Investig Dermatol. 2010;127:27726–39.

    Google Scholar 

  6. Wiebe S, Guyatt G, Weaver B, et al. Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol. 2003;56:52–60.

    Article  PubMed  Google Scholar 

  7. Chren MM, Lasek RJ, Floke SA, et al. Improved discriminative and evaluative capability of a refine version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol. 1997;133:1433–40.

    Article  CAS  PubMed  Google Scholar 

  8. Finlay A, Khan G. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210–6.

    Article  CAS  PubMed  Google Scholar 

  9. Fine JD, Johnson LB, Weiner M, et al. Assessment of mobility, activities and pain in different subtypes of epidermolysis bullosa. Clin Exp Dermatol. 2004;29:122–7.

    Article  PubMed  Google Scholar 

  10. Fine JD, Johnson LB, Weiner M, et al. Impact of inherited epidermolysis bullosa on parental interpersonal relationships, marital status and family size. Br J Dermatol. 2005;152:1009–14.

    Article  PubMed  Google Scholar 

  11. Tabolli S, Sampogna F, Di Pietro C, et al. Quality of life in patients with epidermolysis bullosa. Br J Dermatol. 2009;161:869–77.

    Article  CAS  PubMed  Google Scholar 

  12. Margari F, Leece PA, Santamato W, et al. Psychiatric symptoms and quality of life in patients affected by epidermolysis bullosa. J Clin Psychol Med Settings. 2010;17:333–9.

    Article  PubMed  Google Scholar 

  13. Feldmann R, Weglage J, Frosch M. Cognitive function in patients with epidermolysis bullosa: social adjustment and emotional problems. Klin Padiatr. 2012;224:22–5.

    Article  CAS  PubMed  Google Scholar 

  14. Van Scheppingen C, Lettinga AT, Duipmans JC, et al. Main problems experienced by children with epidermolysis bullosa: a qualitative study with semi-structured interviews. Acta Derm Venereol. 2008;88:143–50.

    Article  PubMed  Google Scholar 

  15. Dures E, Morris M, Gleeson K, Rumsey N. The psychosocial impact of epidermolysis bullosa. Qual Health Res. 2011;21:771–8.

    Article  PubMed  Google Scholar 

  16. Frew DF, Venugopal JW, Murrell SS. Quality of life outcomes of cultured allogeneic fibroblast therapy recipients with epidermolysis bullosa. Aust J Dermatol. 2011;52:S1. p. 26.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dédée F. Murrell MA(Camb), BMBCh(Oxf), FAAD, MD, FACD, FRCP .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Frew, J.W., Murrell, D.F. (2015). Living with Epidermolysis Bullosa: Reviewing the Impact on Individuals’ Quality of Life. In: Murrell, D. (eds) Blistering Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45698-9_74

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-45698-9_74

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-45697-2

  • Online ISBN: 978-3-662-45698-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics